Finasteride for chemoprevention of prostate cancer: why has it not been embraced?
de Vere White
Ralph W
RW
D002140:California; D018890:Chemoprevention / Q000379:methods*; D042241:Early Diagnosis; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis
D004791:Enzyme Inhibitors; D018120:Finasteride